EquityFlow
›
Companies
› Hedera Dx
Hedera Dx
Biotech
· Lausanne, CH ·
hedera.bio
Techbio company building liquid-biopsy solutions for cancer detection
Funding history
Date
Round
Amount
Sep 2022
Seed
Hedera Dx, a Swiss liquid-biopsy techbio, raised €14M led by Top Harvest Capital to launch blood-based cancer testing.
$14M
Investors
Air Street Capital
Top Harvest Capital
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →